Raytheon (RTN)
After stagnating for years, U.S. military spending is likely to pick up once Donald Trump takes office. That should boost sales for Raytheon, which makes military products—from Patriot missiles to electronic warfare systems. The firm’s order backlog hit $35.8 billion in the third quarter of 2016, up by $2.2 billion from a year earlier. FPatriot oreign sales, about one-third of the total, are also rising. Bank of America Merrill Lynch says Raytheon will be a “beneficiary of a global arms race.”
Regeneron Pharmaceuticals (REGN)
Biotech firm Regeneron makes one of the top-selling drugs to prevent eye diseases in the elderly. That product, Eylea, accounts for about two-thirds of the firm’s sales, estimated at $5 billion in 2016. The company may soon win regulatory approval for a new drug for rheumatoid arthritis, and it has several other promising drugs in late-stage studies.
Salesforce.com (CRM)
Salesforce.com is a rapidly expanding company that sells web-based software that helps companies manage relationships with their customers. Terry Tillman, a technology analyst with Raymond James, sees revenues rising by 25% in the fiscal year that ends January 31, 2017, and by 21% for the following year.
Sanofi (SNY)
The 43-year-old company is a major name in drugs for diabetes, cancer and rare diseases. Few companies receive top rankings for both timeliness and safety from the Value Line Investment Survey.
Simon Property Group (SPG)
Like Crown Castle International, Simon Property Group is a real estate investment trust, with regional malls and outlet shopping centers around the world. Simon’s stock has been flat since the start of 2015 as enthusiasm for REITs has waned (though it’s still the largest by market cap).
Starbucks (SBUX)
Starbucks, which needs no introduction, has suffered of late, sinking 2.6% over the past year. That makes it even more attractive especially with no serious competitors on the horizon, a gorgeous balance sheet, and earnings that Value Line predicts will rise 16% annually over the next five years.
Take-Two Interactive Software (TTWO)
You many not have heard of Take-Two Interactive, but you’ve probably heard of at least one of the games it makes: Grand Theft Auto. With a market capitalization of $4.3 billion, Take-Two has about $1.5 billion in cash and short-term investments and just $512 million in debt.
Read more:
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
Disclaimer:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.